Did You Know?

Editor’s Picks

Latest News

iTolerance, Inc. Announces Formation of Scientific Advisory Board with Appointment of International Leaders in Immune Tolerance Discoveries

- Inaugural appointments include scientific founders of iTolerance's regenerative cell therapy pipeline with expertise across biomaterials, immune modulators, and pancreatic...

SCYNEXIS Announces Hansoh Pharma’s Application to National Medical Products Administration (NMPA) in China for Phase 3 Trial of Ibrexafungerp for Treatment of Vulvovaginal Candidiasis (VVC)

Submission is part of the Hansoh Pharma licensing agreement and strategic partnership to research, develop and commercialize ibrexafungerp in the...

error: Content is protected !!